Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Industry Group: Pharmaceuticals
Country/Region: China
Identifier: HKG:2196
Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Pharmaceuticals 620 out of 923
Universe
Global Universe 12599 out of 16353
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Elanco Animal Health, Inc. |
20.2
Medium
|
87 out of 923 |
Ono Pharmaceutical Co., Ltd. |
22.3
Medium
|
124 out of 923 |
Aurobindo Pharma Ltd. |
31.9
High
|
612 out of 923 |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
32.1
High
|
620 out of 923 |
Beijing TongRenTang Co., Ltd. |
37.6
High
|
851 out of 923 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s Management of ESG Material Risk is Average
How do the ESG Risk Ratings work?
Top Material ESG Issues for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Understand how exposed companies are to specific material ESG issues and how well companies are managing these issues.
What are Material ESG Issues?
Material ESG issues are issues that are considered to be financially material to a given company in a relevant sub-industry.
Controversy Rating
Highest Controversy level that has impacted Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s ESG Risk Rating in the last three years
Highest Controversy Level